All Stories

  1. Visual versus region-of-interest based diffusion evaluation and their diagnostic impact in adult-type diffuse gliomas
  2. Comparative evaluation of single- and multi-delay arterial spin labeling MRI in preterm neonates
  3. Age-related changes in cerebral blood flow and arterial transit time in children: insights from single- and multi-delay ASL
  4. Effect of metabolic syndrome severity on cerebral haemodynamics and cognition in community-based cohort
  5. Cerebral perfusion differences in the visual cortex and fusiform subregions across the psychosis spectrum
  6. Multi-cohort, multi-sequence harmonisation for cerebrovascular brain age
  7. Blood-brain barrier water permeability across the adult lifespan: A multi-echo ASL study
  8. Associations between potential risk factors and blood-brain barrier water permeability in middle-aged and older adults
  9. Advantages and challenges of using arterial spin labelling MRI to monitor cerebral blood flow in multi-centre clinical trials of neurodegenerative disease: Experience from the RADAR study
  10. Multi-cohort, multi-sequence harmonisation for cerebrovascular brain age
  11. Associations of life-course cardiovascular risk factors with late-life cerebral hemodynamics
  12. Preoperative prediction of diffuse glioma type and grade in adults: a gadolinium-free MRI-based decision tree
  13. Human performance in predicting enhancement quality of gliomas using gadolinium‐free MRI sequences
  14. Deep learning based bilateral filtering for edge-preserving denoising of respiratory-gated PET
  15. Ten Years of VASARI Glioma Features: Systematic Review and Meta-Analysis of Their Impact and Performance
  16. Longitudinal cerebral perfusion in presymptomatic genetic frontotemporal dementia: GENFI results
  17. Reproducibility of arterial spin labeling cerebral blood flow image processing: A report of the ISMRM open science initiative for perfusion imaging (OSIPI) and the ASL MRI challenge
  18. A guide to advanced MRI processing for clinical glioma research
  19. Developing blood-brain barrier arterial spin labelling as a non-invasive early biomarker of Alzheimer’s disease (DEBBIE-AD): a prospective observational multicohort study protocol
  20. Brain Tumor Imaging without Gadolinium-based Contrast Agents: Feasible or Fantasy?
  21. Diffuse glioma molecular profiling with arterial spin labeling and dynamic susceptibility contrast perfusion MRI: A comparative study
  22. MRI-based parameter inference for cerebral perfusion modelling in health and ischaemic stroke
  23. ASL lexicon and reporting recommendations: A consensus report from the ISMRM Open Science Initiative for Perfusion Imaging (OSIPI)
  24. ISMRM Open Science Initiative for Perfusion Imaging (OSIPI): ASL pipeline inventory
  25. Effect of Physical Exercise on MRI‐Assessed Brain Perfusion in Chemotherapy‐Treated Breast Cancer Patients: A Randomized Controlled Trial
  26. Genetic, vascular and amyloid components of cerebral blood flow in a preclinical population
  27. Imaging blood-brain barrier dysfunction: A state-of-the-art review from a clinical perspective
  28. Supplementary Figure SF1 from Final Results of the Prospective Biomarker Trial PETra: [<sup>11</sup>C]-MET-Accumulation in Postoperative PET/MRI Predicts Outcome after Radiochemotherapy in Glioblastoma
  29. Supplementary Data S1-2 from Final Results of the Prospective Biomarker Trial PETra: [<sup>11</sup>C]-MET-Accumulation in Postoperative PET/MRI Predicts Outcome after Radiochemotherapy in Glioblastoma
  30. Supplementary Data from Final Results of the Prospective Biomarker Trial PETra: [<sup>11</sup>C]-MET-Accumulation in Postoperative PET/MRI Predicts Outcome after Radiochemotherapy in Glioblastoma
  31. Data from Final Results of the Prospective Biomarker Trial PETra: [<sup>11</sup>C]-MET-Accumulation in Postoperative PET/MRI Predicts Outcome after Radiochemotherapy in Glioblastoma
  32. Supplementary Data S1-2 from Final Results of the Prospective Biomarker Trial PETra: [<sup>11</sup>C]-MET-Accumulation in Postoperative PET/MRI Predicts Outcome after Radiochemotherapy in Glioblastoma
  33. Supplementary Figure SF3 from Final Results of the Prospective Biomarker Trial PETra: [<sup>11</sup>C]-MET-Accumulation in Postoperative PET/MRI Predicts Outcome after Radiochemotherapy in Glioblastoma
  34. Supplementary Figure SF2 from Final Results of the Prospective Biomarker Trial PETra: [<sup>11</sup>C]-MET-Accumulation in Postoperative PET/MRI Predicts Outcome after Radiochemotherapy in Glioblastoma
  35. Supplementary Data from Final Results of the Prospective Biomarker Trial PETra: [<sup>11</sup>C]-MET-Accumulation in Postoperative PET/MRI Predicts Outcome after Radiochemotherapy in Glioblastoma
  36. Supplementary Figure SF1 from Final Results of the Prospective Biomarker Trial PETra: [<sup>11</sup>C]-MET-Accumulation in Postoperative PET/MRI Predicts Outcome after Radiochemotherapy in Glioblastoma
  37. Data from Final Results of the Prospective Biomarker Trial PETra: [<sup>11</sup>C]-MET-Accumulation in Postoperative PET/MRI Predicts Outcome after Radiochemotherapy in Glioblastoma
  38. Supplementary Figure SF3 from Final Results of the Prospective Biomarker Trial PETra: [<sup>11</sup>C]-MET-Accumulation in Postoperative PET/MRI Predicts Outcome after Radiochemotherapy in Glioblastoma
  39. Supplementary Figure SF2 from Final Results of the Prospective Biomarker Trial PETra: [<sup>11</sup>C]-MET-Accumulation in Postoperative PET/MRI Predicts Outcome after Radiochemotherapy in Glioblastoma
  40. AdvancedMRTechniques for Preoperative Glioma Characterization: Part 2
  41. Advanced MR Techniques for Preoperative Glioma Characterization: Part 1
  42. The value of arterial spin labelling perfusion MRI in brain age prediction
  43. Current state and guidance on arterial spin labeling perfusion MRI in clinical neuroimaging
  44. Editorial for “MRI Assessment of Cerebral Blood Flow in Nonhospitalized Adults Who Self‐Isolated Due to COVID‐19”
  45. Association of Arterial Spin Labeling Parameters With Cognitive Decline, Vascular Events, and Mortality in a Memory-Clinic Sample
  46. Reply: Cerebral Blood Flow of the Frontal Lobe in Untreated Children with Trigonocephaly versus Healthy Controls: An Arterial Spin Labeling Study
  47. Arterial Spin-Labeling Parameters and Their Associations with Risk Factors, Cerebral Small-Vessel Disease, and Etiologic Subtypes of Cognitive Impairment and Dementia
  48. MRI-based computational model generation for cerebral perfusion simulations in health and ischaemic stroke
  49. ASL-BIDS, the brain imaging data structure extension for arterial spin labeling
  50. Recent Technical Developments in ASL: A Review of the State of the Art
  51. A Beginner's Guide to Arterial Spin Labeling (ASL) Image Processing
  52. Reproducibility of 3 T APT‐CEST in Healthy Volunteers and Patients With Brain Glioma
  53. Cerebral Blood Flow of the Frontal Lobe in Untreated Children with Trigonocephaly versus Healthy Controls: An Arterial Spin Labeling Study
  54. Atherosclerotic risk is associated with cerebral perfusion – A cross-sectional study using arterial spin labeling MRI
  55. The Open-Access European Prevention of Alzheimer’s Dementia (EPAD) MRI dataset and processing workflow
  56. Cerebral perfusion and the risk of cognitive decline and dementia in community dwelling older people
  57. A systematic review on the use of quantitative imaging to detect cancer therapy adverse effects in normal-appearing brain tissue
  58. ASL-BIDS, the brain imaging data structure extension for arterial spin labeling
  59. The European Prevention of Alzheimer’s Dementia (EPAD) MRI Dataset and Processing Workflow
  60. Using Perfusion Contrast for Spatial Normalization of ASL MRI Images in a Pediatric Craniosynostosis Population
  61. Epileptogenic zone detection in MRI negative epilepsy using adaptive thresholding of arterial spin labeling data
  62. Overestimation of grey matter atrophy in glioblastoma patients following radio(chemo)therapy
  63. Arterial spin labeling: Adaptive thresholding for epileptogenic zone detection in MRI-negative epilepsy
  64. Final Results of the Prospective Biomarker Trial PETra: [11C]-MET-Accumulation in Postoperative PET/MRI Predicts Outcome after Radiochemotherapy in Glioblastoma
  65. The Effects of Intracranial Stenosis on Cerebral Perfusion and Cognitive Performance
  66. From research to clinical practice: a European neuroradiological survey on quantitative advanced MRI implementation
  67. Longitudinal relation between blood pressure, antihypertensive use and cerebral blood flow, using arterial spin labelling MRI
  68. GliMR: Cross-Border Collaborations to Promote Advanced MRI Biomarkers for Glioma
  69. Effects of Acquisition Parameter Modifications and Field Strength on the Reproducibility of Brain Perfusion Measurements Using Arterial Spin-Labeling
  70. ExploreASL: An image processing pipeline for multi-center ASL perfusion MRI studies
  71. Dose dependent cerebellar atrophy in glioma patients after radio(chemo)therapy
  72. Accurate MR Image Registration to Anatomical Reference Space for Diffuse Glioma
  73. Hemodynamic impairments within individual watershed areas in asymptomatic carotid artery stenosis by multimodal MRI
  74. Spatial coefficient of variation of arterial spin labeling MRI as a cerebrovascular correlate of carotid occlusive disease
  75. Cerebral oxygen metabolism in adults with sickle cell disease
  76. ExploreASL: an image processing pipeline for multi-center ASL perfusion MRI studies
  77. Late-life brain perfusion after prenatal famine exposure
  78. Cortical microinfarcts in memory clinic patients are associated with reduced cerebral perfusion
  79. Cerebral perfusion changes in presymptomatic genetic frontotemporal dementia: a GENFI study
  80. Cerebrovascular Reactivity during Prolonged Breath-Hold in Experienced Freedivers
  81. Photon vs. proton radiochemotherapy: Effects on brain tissue volume and perfusion
  82. Effects of systematic partial volume errors on the estimation of gray matter cerebral blood flow with arterial spin labeling MRI
  83. EP-2137: Development of a modular MRI processing workflow for volumetric analysis of healthy brain tissue
  84. OC-0594: Postoperative [11C]MET-PET predicts radiochemotherapy outcome in glioblastoma: a prospective trial
  85. Comparison of arterial spin labeling registration strategies in the multi-center GENetic frontotemporal dementia initiative (GENFI)
  86. The spatial coefficient of variation in arterial spin labeling cerebral blood flow images
  87. Moments-Based Ultrasound Visual Servoing: From a Mono- to Multiplane Approach
  88. Early and late effects of radiochemotherapy on cerebral blood flow in glioblastoma patients measured with non-invasive perfusion MRI
  89. Correction of quantification errors in pelvic and spinal lesions caused by ignoring higher photon attenuation of bone in [18F]NaF PET/MR
  90. Evaluation of in vivo quantification accuracy of the Ingenuity-TF PET/MR
  91. Accuracy of Parenchymal Cerebral Blood Flow Measurements Using Pseudocontinuous Arterial Spin-Labeling in Healthy Volunteers
  92. Partial Volume Correction of Cerebral Perfusion Estimates Obtained by Arterial Spin Labeling
  93. Stability of MR brain-perfusion measurement using arterial spin labeling
  94. Evaluation and automatic correction of metal-implant-induced artifacts in MR-based attenuation correction in whole-body PET/MR imaging
  95. Erratum to: Quantitative accuracy of attenuation correction in the Philips Ingenuity TF whole-body PET/MR system: a direct comparison with transmission-based attenuation correction
  96. Correction of scan time dependence of standard uptake values in oncological PET
  97. Modeling magnetization transfer effects of Q2TIPS bolus saturation in multi-TI pulsed arterial spin labeling
  98. Influence and Compensation of Truncation Artifacts in MR-Based Attenuation Correction in PET/MR
  99. Template-based approach for detecting motor task activation-related hyperperfusion in pulsed ASL data
  100. The PET-derived tumor-to-blood standard uptake ratio (SUR) is superior to tumor SUV as a surrogate parameter of the metabolic rate of FDG
  101. An automatic method for accurate volume delineation of heterogeneous tumors in PET
  102. Optimal Individual Inversion Time in Brain Arterial Spin Labeling Perfusion Magnetic Resonance Imaging
  103. Partial volume correction in arterial spin labeling using a Look-Locker sequence
  104. Quantitative accuracy of attenuation correction in the Philips Ingenuity TF whole-body PET/MR system: a direct comparison with transmission-based attenuation correction
  105. Functional arterial spin labeling: Optimal sequence duration for motor activation mapping in clinical practice
  106. Arterial spin labelling fonctionnel : durée de séquence optimale pour cartographier l’activation motrice en routine clinique
  107. Improving quality of arterial spin labeling MR imaging at 3 tesla with a 32-channel coil and parallel imaging
  108. A method for model-free partial volume correction in oncological PET
  109. Innovations en IRM fonctionnelle cérébrale : marquage de spins artériels et diffusion
  110. Arterial spin labeling for motor activation mapping at 3T with a 32-channel coil: Reproducibility and spatial accuracy in comparison with BOLD fMRI
  111. Evaluation of functional arterial spin labeling data using a perfusion template
  112. Construction and evaluation of a quantitative arterial spin labeling brain perfusion template at 3T
  113. Improving arterial spin labeling data by temporal filtering
  114. Denoising arterial spin labeling MRI using tissue partial volume
  115. Continuous criterion for parallel MRI reconstruction using B-spline approximation (PROBER)
  116. Parallel image reconstruction using B-spline approximation (PROBER)
  117. Fast parallel MRI reconstruction using B-spline approximation (PROBER)